Mar 29, 2022 / 12:00PM GMT
Tyler Ehler -
Allow me to welcome you all to the I-Mab Biopharma Full Year 2021 Financial Results and Business Update Conference Call. This is Tyler Ehler here, I-Mab's Senior Director of Investor Relations. (Operator Instructions) Later, we will conduct a Q&A session and instructions will follow at that time.
Earlier today, we issued a press release providing a review of our financial results for the full year ended December 31, 2021, as well as an overview of our recent corporate highlights and upcoming milestones. The press release can be accessed on the Investors portion of our website at ir.i-mabbiopharma.com.
Joining me today on the call from I-Mab's senior management team are Dr. Jingwu Zang, our Founder Chairman and Acting CEO of I-Mab; Dr. Andrew Zhu, our President of I-Mab; Mr. John Long, CFO of I-Mab; and Mr. Jielun Zhu, Chief Strategy Officer of I-Mab.
Dr. Zang will start by providing a high-level overview of our recent achievements and upcoming milestones, followed by Dr. Andrew Zhu, who will provide an update on our R&D progress; and Mr. Zhu, who will provide an
Full Year 2021 I-Mab Earnings Call Transcript
Mar 29, 2022
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers